FDA banned dietary supplements containing ephedrine alkaloids
On Feb. 9, 2004, deeming such products to present an unreasonable risk of harm, the FDA banned dietary…
The U.S. Congress enacted the Sun Grant Research Initiative Act
On Jan. 23, 2004, the U.S. Congress enacted the Sun Grant Research Initiative Act. The Sun Grant Research…
Siemens introduced Acuris, the first hearing instrument featuring a wireless system, e2e wireless, small enough to fit in CICs
In 2004, Siemens, now Sivantos, introduced Acuris, the first hearing instrument featuring a wireless system, e2e wireless, small…
FDA issued public health advisory urging health professionals to limit the use of Cox-2 selective agents
In 2004, Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib) because of an increased risk of heart…
The Kansas Bioscience Authority was founded
In 2004, Kansas Bioscience Authority was created in April 2004 when Governor Kathleen Sebelius signed into law the…
Touro University was founded
In 2004, Touro University Nevada (TUN), located in Henderson, was founded as a private, non-profit institution of higher…
The Pearson Center for Research on Alcoholism and Addiction was established at the Scripps Research Institute
On Dec. 15, 2003, the Pearson Center for Research on Alcoholism and Addiction was established at the Scripps…
An obesity working group is established by the Commissioner of Food and Drugs
On Oct. 8, 2003, an obesity working group was established by the Commissioner of Food and Drugs, charged…
American chemist Paul Lauterbur and British physicist Peter Mansfield shared the 2003 Nobel Prize in Physiology or Medicine
On Oct. 6, 2003, American chemist Paul Lauterbur and British physicist Peter Mansfield made pioneering contributions during the…
Winship Cancer Institute received a $19 million National Cancer Institute Planning Grant
On Sept. 29, 2003, Winship Cancer Institute (WCI) at Emory University received a $1.9 million National Cancer Institute…
FDA approved an expanded indication for ENBREL (etanercept) to inhibit progression of structural damage of active arthritis
On Aug. 25, 2003, the FDA approved an expanded indication for ENBREL (etanercept) to inhibit the progression of…
Results from the Prostate Cancer Prevention Trial showed men taking finasteride had 25 percent fewer diagnoses of prostate cancer than men taking placebo
On Jul. 17, 2003, the results from the Prostate Cancer Prevention Trial (PCPT) were published in New England…
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Life Science History | Therapeutics | Vaccine
The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
The FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma
On May 13, 2003, the FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma. In…
Cancer Control PLANET, a web portal providing access to regularly updated cancer surveillance data, was launched
On Apr. 24, 2003, the National Cancer Institute, CDC, AHRQ, and SAMHSA, in collaboration with the American Cancer…
Dr. Vincent Poitout at the Pacific Northwest Research Foundation won the Thomas R Lee Award from the American Diabetes Association
On Apr. 23, 2003, Dr. Vincent Poitout at the Pacific Northwest Research Foundation (PNRF) won the Thomas R….
Winship Cancer Institute opened a new, 280,000-square-foot, state-of-the-art facility
In Sept. 2003, Emory’s Winship Cancer Institute opened a new, 280,000-square-foot, state-of-the-art facility, adding new research and high-tech…
The Arizona Nanotechnology Cluster was founded
In Jan. 2003, the Arizona Nanotechnology Cluster, an Arizona not-for-profit organization, was formed to share technological advances, and…
The EPA approved the first transgenic rootworm-resistant corn
In 2003, the U.S. Environmental Protection Agency (EPA) approved the first transgenic rootworm-resistant corn developed by Monsanto under…
Over 1,000 of NNMC’s medical staff members deployed on the USNS COMFORT serving in the Persian Gulf
In 2003, over 1,000 of NNMC’s medical staff members deployed on the USNS COMFORT serving in the Persian…
The FDA Office of Combination Products was formed
On Dec. 24, 2002, the FDA’s Office of Combination Products was formed within the Office of the Commissioner,…
NCI researchers discovered a molecule called Beta-defensin 2 that activates an immune response
On Oct. 31, 2002, National Cancer Institute (NCI) researchers announced they had discovered that a molecule best known…
Under the Medical Device User Fee and Modernization Act, fees were assessed sponsors of medical device applications
On Oct. 26, 2002, under the Medical Device User Fee and Modernization Act, fees are assessed sponsors of…
NCI and FDA scientists reported patterns of proteins found in patients’ blood can distinguish between prostate cancer and benign conditions
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
National Cancer Institute researchers replace a patient’s immune system with cancer-fighting cells
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
FDA announced initiative to modernize the regulation of pharmaceutical manufacturing
On Aug. 21, 2002, the FDA announced an initiative to modernize the regulation of pharmaceutical manufacturing and product…
The FDA announced the current good manufacturing practice (cGMP) initiative
On Aug. 21, 2002, the FDA announced an effort to enhance and update the regulation of manufacturing processes…
Dr. Julie Louise Gerberding became the first woman Director of the Centers for Disease Control and Prevention
On Jul. 3, 2002, Dr. Julie Louise Gerberding, M.D., M.P.H., became the first woman Director of the Centers…
Biotechnology | Diagnostics | Disease | Life Science History | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
The FDA approved the first nucleic acid test system to screen whole blood donors for infections with HIV and HCV
On Feb. 28, 2002, the FDA announced it had licensed the first nucleic acid test (NAT) system intended…